JANSSEN GLOBAL SERVICES LLC

In News

J&J Unit Wants Forensic Exam Of Ex-Director's Devices - Law360

Law360 - Mar 30, 2026

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer - Johnson & Johnson

Johnson & Johnson - Jul 17, 2025

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer - Johnson & Johnson

Johnson & Johnson - Jul 17, 2025

Janssen to stop clinical development of pimodivir for influenza - Clinical Trials Arena

Clinical Trials Arena - Sep 03, 2020

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting - PR Newswire

PR Newswire - Nov 19, 2024

Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus - Investing News Network

Investing News Network - Mar 03, 2026

Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database - Nature

Nature - Dec 05, 2024

Janssen Expands Research & Development Presence with Major Investment in South San Francisco - Business Wire

Business Wire - Jan 10, 2020

J&J Unit Sues Ex-Employee to Block Use of Confidential File Data - Bloomberg Law News

Bloomberg Law News - Mar 13, 2026

Janssen’s Stelara shows remission in Crohn’s disease patients - Clinical Trials Arena

Clinical Trials Arena - Feb 17, 2020

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer - PR Newswire

PR Newswire - Jan 15, 2025

J&J Unit Says Ex-Director Misappropriated Trade Secrets - Law360

Law360 - Mar 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment